Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Lowe

Showing results (21-30 of 196) with videos related to

Pageof 20
Sort By:
Women'S Health (London, England)|October 7, 2009
Update on the cardiovascular risks of hormone replacement therapyGordon D O Lowe
Journal of Internal Medicine|October 16, 2004
Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart diseaseG D O Lowe
Journal of Thrombosis and Haemostasis : JTH|August 17, 2005
Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular diseaseG D O Lowe
British Journal of Haematology|April 29, 2006
Can haematological tests predict cardiovascular risk? The 2005 Kettle LectureGordon D O Lowe
Journal of Thrombosis and Haemostasis : JTH|August 15, 2012
Epidemiology of venous thromboembolism: the need for large (including prospective) studies and meta-analysesG D O Lowe
Journal of Thrombosis and Haemostasis : JTH|March 6, 2008
Coagulation, genotypes and recurrent cardiovascular events: what further studies are required?G D O Lowe
Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
Coagulation factors, activation markers and risk of coronary heart disease: the Northwick Park Heart StudiesG D O Lowe
Journal of Thrombosis and Haemostasis : JTH|March 29, 2007
Inflammatory/hemostatic biomarkers and cardiovascular risk: coming of age?G D O Lowe
Clinical Chemistry|March 30, 2010
Fibrinogen assays for cardiovascular risk assessmentGordon D O Lowe
The Journal of Pedodontics|January 1, 1985
Generalized odontodysplasiaO Lowe, D F Duperon
Pageof 20

Showing results (21-30 of 196) with videos related to

Sort By:
Pageof 20
Women'S Health (London, England)|October 7, 2009
Update on the cardiovascular risks of hormone replacement therapyGordon D O Lowe
Journal of Internal Medicine|October 16, 2004
Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart diseaseG D O Lowe
Journal of Thrombosis and Haemostasis : JTH|August 17, 2005
Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular diseaseG D O Lowe
British Journal of Haematology|April 29, 2006
Can haematological tests predict cardiovascular risk? The 2005 Kettle LectureGordon D O Lowe
Journal of Thrombosis and Haemostasis : JTH|August 15, 2012
Epidemiology of venous thromboembolism: the need for large (including prospective) studies and meta-analysesG D O Lowe
Journal of Thrombosis and Haemostasis : JTH|March 6, 2008
Coagulation, genotypes and recurrent cardiovascular events: what further studies are required?G D O Lowe
Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
Coagulation factors, activation markers and risk of coronary heart disease: the Northwick Park Heart StudiesG D O Lowe
Journal of Thrombosis and Haemostasis : JTH|March 29, 2007
Inflammatory/hemostatic biomarkers and cardiovascular risk: coming of age?G D O Lowe
Clinical Chemistry|March 30, 2010
Fibrinogen assays for cardiovascular risk assessmentGordon D O Lowe
The Journal of Pedodontics|January 1, 1985
Generalized odontodysplasiaO Lowe, D F Duperon
Pageof 20